Form 4: Quest Diagnostics Director Acquires Shares

Quest Diagnostics Director Vicky B. Gregg acquired 1,142 shares of common stock through an award of restricted stock units.

Summary

• Vicky B. Gregg, a Director at Quest Diagnostics Inc., acquired 1,142 shares of common stock on May 20, 2026.
• The acquisition was made through an award of restricted stock units.
• Following this transaction, Gregg beneficially owns 18,314 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction (award of restricted stock units) rather than a significant strategic move or financial performance indicator.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition was made at a price of $0, indicating it was an award rather than a purchase, which is a common form of executive compensation.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of restricted stock units by a director, are common in the healthcare diagnostics industry as a form of executive compensation and incentive alignment.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of internal confidence, though the impact on share price is likely minimal given it's an award.

Key Dates

Keywords

Quest Diagnostics, DGX, Form 4, Insider Trading, Restricted Stock Units, Director Acquisition, Beneficial Ownership